Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reduced Intensity Conditioning Allogenic Transplant for Myeloma (IFM 2005-03)
NCT00466674Phase 2Completed
- Sponsor
- Hospices Civils de Lyon
- Start
- Jan 2007
- Primary completion
- Sep 2013
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan, antithymocyte globulin rabbit in multiple myeloma (MM), sponsored by Hospices Civils de Lyon. Started Jan 2007; status: completed.
02
Drugs
fludarabinebusulfanantithymocyte globulin rabbit
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00466674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466674.